v3.26.1
Accrued Expenses and Other Current Liabilities
6 Months Ended
Jun. 30, 2026
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities

7. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

 

 

 

June 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

 

 

(in thousands)

 

Vaxcyte-related accrual under Vaxcyte Supply Agreement

 

$

7,124

 

 

$

12,713

 

CMO-related accrual

 

 

7,251

 

 

 

5,853

 

Clinical trials-related accrual

 

 

1,632

 

 

 

504

 

Restructuring related accrual

 

 

11,506

 

 

 

12,598

 

Other

 

 

2,728

 

 

 

2,913

 

Total accrued expenses and other current liabilities

 

$

30,241

 

 

$

34,581